rs869025203
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_001349338.3(FOXP1):c.1540C>T(p.Arg514Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/20 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R514H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001349338.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXP1 | NM_001349338.3 | c.1540C>T | p.Arg514Cys | missense_variant | Exon 18 of 21 | ENST00000649528.3 | NP_001336267.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXP1 | ENST00000649528.3 | c.1540C>T | p.Arg514Cys | missense_variant | Exon 18 of 21 | NM_001349338.3 | ENSP00000497369.1 | |||
ENSG00000285708 | ENST00000647725.1 | c.1540C>T | p.Arg514Cys | missense_variant | Exon 23 of 26 | ENSP00000497585.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:6
Not observed in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 26647308, 31199603, 28741757, 34109629, 31981491) -
- -
- -
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 514 of the FOXP1 protein (p.Arg514Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with intellectual disability syndrome (PMID: 26647308). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 217265). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FOXP1 protein function with a positive predictive value of 80%. This variant disrupts the p.Arg514 amino acid residue in FOXP1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 28741757). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
- -
PS3, PM2, PM6, PS4_Moderate -
Intellectual disability-severe speech delay-mild dysmorphism syndrome Pathogenic:4
- -
- -
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as pathogenic. Following criteria are met: 0103 - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with intellectual disability with language impairment and with or without autistic features (MIM#613670). Loss of function leading to haploinsufficiency has been demonstrated, however some variants have also been shown to bind to wild type FOXP1 and affect wild type function and localisation (PMID: 26647308). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to cysteine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0601 - Variant is located in the well-established functional forkhead domain. Moreover, the affected residue is a DNA binding site (Decipher; NCBI conserved domain). (SP) 0704 - Another missense variant comparable to the one identified in this case has limited previous evidence for pathogenicity. The p.(Arg514His) variant is de novo in three unrelated individuals with mild to severe intellectual disability (PMID: 28741757). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant is de novo in two individuals with intellectual disability (ClinVar, PMID: 26647308). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1002 - This variant has moderate functional evidence supporting abnormal protein function. Mutant constructs transfected into HEK293T cells resulted in reduced protein expression with subsequent mis-localisation and reduced transcriptional repression ability of the protein (PMID: 26647308). (SP) 1204 - This variant has been shown to be de novo in the proband (parental status not tested but assumed). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
The c.1540C>T;p.(Arg514Cys) missense variant has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 217265; PMID: 26647308) - PS4.The variant is located in a mutational hot spot and/or critical and well-established functional domain (Forkhead domain) - PM1. This variant is not present in population databases (rs869025203, gnomAD; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2. Pathogenic missense variant in this residue have been reported (PMID: 28741757 - c.1541G>A (p.Arg514His) - ) - .PM5. Multiple lines of computational evidence support a deleterious effect on the gene or gene product - PP3. In summary, the currently available evidence indicates that the variant is pathogenic. -
FOXP1-related disorder Pathogenic:1
The FOXP1 c.1540C>T variant is predicted to result in the amino acid substitution p.Arg514Cys. This variant has been reported de novo in individuals with global developmental disorder, intellectual disability, and/or speech and language delay (Sollis et al. 2015. PubMed ID: 26647308; Braden et al. 2021. PubMed ID: 34109629). Function studies have shown that this variant impacts protein function (Sollis et al. 2015. PubMed ID: 26647308; Estruch et al. 2018. PMID: 29365100). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare, and is interpreted as pathogenic in ClinVar by several laboratories (https://www.ncbi.nlm.nih.gov/clinvar/variation/217265/). This variant is interpreted as pathogenic. -
INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND AUTISTIC FEATURES Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at